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Abstract
Traumatic brain injury (TBI) is a major cause of death and disability. However, the molecular 
events contributing to the pathogenesis are not well understood. Mitochondria serve as the 
powerhouse of cells, respond to cellular demands and stressors, and play an essential role in cell 
signaling, differentiation, and survival. There is clear evidence of compromised mitochondrial 
function following TBI, however, the underlying mechanisms and consequences are not clear. 
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression post-
transcriptionally, and function as important mediators of neuronal development, synaptic 
plasticity, and neurodegeneration. Several miRNAs show altered expression following TBI, 
however, the relevance of mitochondria in these pathways is unknown. Here, we present evidence 
supporting the association of miRNA with hippocampal mitochondria, as well as changes in 
mitochondria-associated miRNA expression following a controlled cortical impact (CCI) injury in 
rats. Specifically, we found that the miRNA processing proteins Argonaute (AGO) and Dicer are 
present in mitochondria fractions from uninjured rat hippocampus, and immunoprecipitation of 
AGO associated miRNA from mitochondria suggests the presence of functional RNA-induced 
silencing complexes. Interestingly, RT-qPCR miRNA array studies revealed that a subset of 
miRNA is enriched in mitochondria relative to cytoplasm. At 12 hour following CCI, several 
miRNAs are significantly altered in hippocampal mitochondria and cytoplasm. In addition, levels 
of miR-155 and miR-223, both of which play a role in inflammatory processes, are significantly 
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elevated in both cytoplasm and mitochondria. We propose that mitochondria-associated miRNAs 
may play an important role in regulating the response to TBI.
Keywords
microRNA; mitochondria; traumatic brain injury; controlled cortical impact; hippocampus; 
inflammation; miR-142-3p; miR-142-5p; miR-146a; miR-155; miR-223; miR-150
Introduction
Traumatic brain injury (TBI) is a major cause of death and disability affecting an estimated 
1.7 million people annually in the United States alone (Faul M, 2010). The personal and 
health consequences associated with TBI are substantial with an estimated annual financial 
burden of over $75 billion in direct medical costs and other indirect costs (Finkelstein et al., 
2006). At the present time, no effective treatment exists due, in part, to the widespread 
impact of numerous complex secondary biochemical and pathophysiological events 
occurring at different time points following the initial injury (McIntosh et al., 1998; 
Rosenfeld et al., 2012). These secondary injury events include, but are not limited to edema, 
excitotoxicity, inflammation, oxidative stress/damage, activation of necrotic and apoptotic 
cell death-signaling events, and impaired mitochondrial function (Rink et al., 1995; Clark et 
al., 2000; Sullivan et al., 2002; Lifshitz et al., 2004; Raghupathi, 2004; Singh et al., 2006; 
Ziebell and Morganti-Kossmann, 2010). Mitochondria play an essential role in maintaining 
cellular homeostasis by responding to cellular energy demands and participating directly in a 
wide range of cellular events including cell signaling, metabolism, and survival, in addition 
to cell death pathways (Saraste, 1999; McBride et al., 2006). Importantly, it has been well 
documented that the degree of mitochondrial dysfunction and recovery following TBI is a 
critical determinant of subsequent cell survival or death (Sullivan et al., 2002; Lifshitz et al., 
2003; Lifshitz et al., 2004; Singh et al., 2006; Pandya et al., 2009; Patel et al., 2009). These 
vital roles for mitochondria in cellular function and survival have resulted in increased 
efforts to identify the molecular events associated with mitochondrial impairment in TBI.
Mitochondria respond rapidly to a wide range of stressors and cellular requirements. Several 
studies have documented the localization of microRNA (miRNA) processing machinery and 
various miRNA in mitochondrial fractions isolated from a variety of cells and tissues (Lung 
et al., 2006; Kren et al., 2009; Bian et al., 2010; Bandiera et al., 2011; Barrey et al., 2011; 
Huang et al., 2011; Mercer et al., 2011; Das et al., 2012; Hu et al., 2012; Sripada et al., 
2012). MiRNAs are short, non-coding RNA molecules that bind to recognition elements in 
mRNA and regulate gene expression post-transcriptionally either by mRNA degradation or 
translational repression (Bartel, 2004; Chen and Rajewsky, 2007; Bartel, 2009; Huntzinger 
and Izaurralde, 2011). Disruption of miRNA function contributes to many disease states 
including cancer, cardiovascular disease, and neurodegeneration (Calin and Croce, 2006; 
Nelson et al., 2008a; Hata, 2013). The biological actions of miRNA are thought to require 
the cytoplasmic processing by Dicer, interaction with Argonaute (AGO) proteins and 
assembly into RNA-induced silencing complexes (RISC) (Liu et al., 2008; Bartel, 2009), 
which promotes and stabilizes miRNA base pair annealing with target mRNA. Recently, 
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mitochondria have been shown to interact with AGO-miRNA containing processing bodies 
(P-bodies), and that mild uncoupling of mitochondria decreases cellular miRNA functional 
efficiency (Huang et al., 2011). The ability of a single miRNA or miRNA family to regulate 
the post-transcriptional expression of hundreds of genes makes them ideal candidates for 
coordinating complex gene expression programs, including modifying a cell’s response to 
stressors or mounting a protective or pathological response following TBI. Recent 
experimental studies have reported altered expression levels of several miRNAs in both 
cortex and hippocampus following controlled cortical impact (CCI), fluid percussion injury, 
and contusive spinal cord injury (Lei et al., 2009; Liu et al., 2009; Redell et al., 2009; Redell 
et al., 2010; Strickland et al., 2011; Truettner et al., 2011; Hu et al., 2012; Yunta et al., 2012; 
Hu et al., 2013; Truettner et al., 2013; Di et al., 2014; Liu et al., 2014; Sabirzhanov et al., 
2014; Sun et al., 2014). However, the signaling events regulating cellular miRNA activity 
and/or function in response to TBI are largely unknown.
In the present study, we demonstrate the presence of miRNA protein machinery in 
mitochondrial fractions of rat hippocampal tissue. In addition, miRNAs were found in AGO-
containing complexes co-immunoprecipitated from purified mitochondria supporting a role 
for mitochondria in regulating miRNA activity. Importantly, a subset of miRNAs was 
preferentially enriched in hippocampal mitochondria preparations under normal conditions, 
and several miRNAs were found to decrease following a severe TBI. These studies point 
towards a novel role for mitochondrial regulation of miRNA expression in response to TBI.
Materials and Methods
Surgical procedures for traumatic brain injury
All procedures and protocols were approved by the University of Kentucky Institutional 
Animal Care and Use Committee. Young adult male Sprague–Dawley rats weighed 250–
300 g (Harlen Laboratories, IN) were housed for 7 days prior to experimentation to allow 
them to acclimate to the environment. All animals were maintained in a temperature-
controlled vivarium room with free access to food and water. The surgical and controlled 
cortical impact (CCI) injury procedures have been described in detail previously (Sullivan et 
al., 1999). Briefly, animals were anesthetized with isoflurane (4%) and placed in a 
stereotaxic frame (David Kopf, Tujunga, CA) prior to brain surgery. Isoflurane (2.5%) was 
delivered via a nose cone throughout the surgical procedure. Using sterile procedures, the 
skin was retracted and a 6-mm craniotomy was made lateral to the sagittal suture and 
centered between bregma and lambda. The skull-cap was carefully removed without 
disruption of the underlying dura. The exposed brain was then injured using a pneumatically 
controlled impacting device consisting of a 5 mm diameter rod tip that compressed the 
cortex at 3.5 m/s velocity to a depth of 2.0 mm. The use of these injury parameters results in 
a severe injury to the cortex overlying the hippocampal formation (Baldwin et al., 1997; 
Davis et al., 2008; Gilmer et al., 2009). Following CCI, the Surgicel (Johnson and Johnson) 
was laid over the dura and the skull-cap was replaced. A thin coat of dental acrylica was 
then spread over the craniotomy site and allowed it to dry before closing the overlying skin 
with surgical staples. The core body temperatures of the animals were maintained at 37 °C 
throughout the surgical procedures and recovery period.
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At 12 hr post-injury, animals were euthanatized with CO2 and the hippocampus from both 
the injured and naïve animals (n=5 animals per group) were rapidly removed. Any potential 
effect of a unilateral CCI on miRNA changes in the contralateral hippocampus has not been 
investigated. Therefore, the hippocampi from naïve, uninjured animals were used to obtain 
control tissue.
Isolation of mitochondria
For studies examining miRNA expression, the nuclear (P1), cytosolic (S2) and purified total 
mitochondria (MT) fractions were isolated from rat hippocampus according to a previously 
published ficoll density gradient procedure (Pandya et al., 2009). Briefly, tissue 
homogenates were prepared in ice-cold mitochondrial isolation buffer (215 mM mannitol, 
75 mM sucrose, 0.1% bovine serum albumin (BSA), 20 mM HEPES, 1 mM EGTA; pH 
adjusted to 7.2 with KOH), followed by centrifugation two times at 1,300 g for 3 min to 
obtain P1. The resulting supernatant was centrifuged at 13,000 g for 10 min to obtain crude 
mitochondrial pellets (P2) and the supernatant was saved as S2. The P2 pellets were re-
suspended in isolation buffer and placed in a nitrogen cell disruption chamber (1200 psi, 10 
min, at 4 °C) to rupture and release synaptosomal mitochondria (Brown et al., 2004). This 
fraction was further purified using a discontinuous ficoll gradient (7.5% layered over 10% 
ficoll) and centrifugation at 100,000 g (in SW 55Ti rotors) at 4 °C for 30 min. The resulting 
MT pellet was washed and centrifuged at 10,000 g at 4 °C for 10 min in mitochondrial 
isolation buffer without EGTA and finally resuspended to achieve a concentration of ~10 
mg/ml in mitochondrial isolation buffer without EGTA for the miRNA expression studies. 
The protein content of the above listed fractions was analyzed using BCA protein assay kit.
Isolation of mitochondrial sub-fractions from ficoll-purified mitochondria
A mitochondria (MT) fraction was obtained from adult naïve rat brain as described above, 
and further processed to generate mitochondrial sub-fractions according to a previously 
published method (Atorino et al., 2003) with slight modifications. Briefly, 5 mg of MT was 
subjected to hypotonic swelling in 1.5 ml of 5 mM HEPES/KOH, pH 7.4 for 20 min on ice 
to rupture the outer mitochondrial membrane. The solution was then centrifuged at 1900 g at 
4 °C for 15 min to obtain a mitoplast pellet (MP) and mitochondrial supernatant (MS) 
containing broken outer mitochondrial membrane and inter-membrane space (IMS) 
compartments. The MS fraction was then sonicated (10 seconds X 3 times) and centrifuged 
35,000 g (utilizing SW 55Ti rotors) further at 4 °C for 15 min to pellet down the outer 
membrane (OM), with the resulting supernatant containing only the inter-membrane space 
(IMS) of mitochondria. The dense MP pellets were re-suspended in 250 μl of ice-cold 
isolation buffer, sonicated (10 seconds X 3 times) and further centrifuged at 100,000 g 
(utilizing SW 55Ti rotors) at 4 °C for 30 min. The resultant membrane-enriched pellet 
contained the mitochondrial inner membrane (IM) and the resulting supernatant contained 
the mitochondrial matrix (MTX) fractions. The protein content of the mitochondrial sub-
fractions was determined using BCA protein assay.
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Western Blot Procedure
The purity of the mitochondria samples as well as identification of miRNA machinery 
proteins in the sub-mitochondrial fractions were analyzed using standard Western blotting 
techniques. Briefly, a total of 15 μg of protein was resolved according to molecular weight 
by SDS–PAGE using either Criterion 4–20% Tris–HCl (10–250 kD) or Criterion 3–8% Tri-
acetate (25–250 kD) gels (Bio-Rad, Hercules, CA). The gels were transblotted onto 
polyvinylidene difluoride membranes, blocked with 5% nonfat dry milk for an hour, and 
then incubated at 4 °C overnight with the primary antibody of interest. The primary 
antibodies used included anti-Dicer mAb (1:500 dilution; cat # sc-136979; Santa Cruz 
Biotechnology, Inc.), anti-Histone 3 rabbit mAb (H3; 1:25,000 dilution; cat # 4499; Cell 
Signaling Technology Inc.), anti-pyruvate dehydrogenase rabbit mAb (PDH; 1:10,000 
dilution; cat # 3205; Cell Signaling Technology Inc.), anti-voltage-dependent anion channel 
rabbit polyAb (VDAC; 1:10,000 dilution; cat # PA1-954A; Thermo Scientific Inc.), anti-
complex IV mAb (CoxIV; 1:200,000 dilution; Cat # A21348; Life Technologies Inc.), anti-
beta tubulin rabbit polyAb (1:100,000 dilution; cat # ab6046; Abcam Inc.), anti-beta actin 
mAb (1:75,000 dilution; cat # A5316; Sigma-Aldrich), anti-CD45 rabbit polyAb (1:2,000 
dilution; cat # ab10558; Abcam Inc.), anti-iNOS (1:10,000 dilution; cat # 610332; BD 
Transduction Laboratories), and anti-Argonaute 2 mAb (2A8; 1:1000 dilution). The 2A8 
Ago2 antibody has been described previously (Nelson et al., 2007). Peroxidase-conjugated 
affinipure secondary antibodies included goat anti-mouse IgG and goat anti-rabbit IgG (cat # 
115-035-166 and 111-035-144, respectively; Jackson ImmunoResearch laboratories, Inc.).
Primary rat brain cell culture
Primary cortical neuronal, astrocyte and microglial cultures were generated from Sprague–
Dawley rat pups at E18 as described previously (Wang et al., 2014).
RNA isolation from mitochondria and cytosol
Total RNA isolation using TRIZOL LS reagent (Life Technologies, USA) from cytosolic 
fractions followed the modified procedure described previously (Nelson et al., 2008b; Wang 
et al., 2008a). Total mitochondrial RNA isolation employed the same procedure with minor 
modifications (double extraction) to accommodate RNA isolation from limited sample 
quantity. Briefly, mitochondria were lysed in 250 μl RIPA buffer (10 mM Tris-Cl (pH 8.0), 
1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS) in 
the presence of protease inhibitors (Pierce, cat. # 78439) and RNasin (0.2 U/μl, Promega, 
cat. # N2615). TRIZOL LS was then added to the mitochondria lysate. After chloroform 
extraction and centrifugation, a 450-μl clear aqua-phase supernatant was saved. The 
remaining 150–200 μl supernatant (which may contain some protein interface) was collected 
separately, and was brought up to 250 μl using RIPA buffer. This supernatant was then 
subjected to a second round of TRIZOL LS extraction following the same procedure. The 
aqua-phase supernatants from both extractions were combined, and total RNA precipitated 
using iso-propanol with glycogen (Roche, cat. # 10901393001) as carrier. Isolated RNA 
concentrations were quantified using NanoDrop1000 Spectrophotometer (NanoDrop 
Technologies, Inc.).
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TaqMan® miRNA RT-qPCR array
Total RNA isolated from mitochondria and cytosol of each hippocampal tissue was 
subjected to TaqMan® miRNA RT-qPCR array using Rodent Card A (Life Technologies). 
Because of the relatively low levels of mitochondrial RNA and the benefit of uniformity, a 
preamplification step using Megaplex™ PreAmp Primers (Life Technologies) was carried 
out to enhance the detection ability for low-expression miRNAs. TaqMan® miRNA RT-
qPCR array was performed as described previously (Wang et al., 2014). Briefly, equal 
amount of total RNA (50 ng) was reverse transcribed using the TaqMan® MicroRNA 
Reverse Transcription Kit with Megaplex™ Primer Pools, Rodent Pool A (Life 
Technologies). The resulting cDNA was pre-amplified using Megaplex™ PreAmp Primers, 
Rodent Pool A (Life Technologies) before performing RT-qPCR Array. PCR was carried 
out on the ViiA™ 7 Real-Time PCR System and qPCR cycle threshold (Ct) raw data 
processed with ViiA 7 RUO software (Life Technologies).
TaqMan® single-tube miRNA RT-qPCR
Individual miRNA was subjected to single-tube TaqMan® assay (Life Technologies) 
according to manufacturer’s instructions. TaqMan® assays were designed to follow MIQE 
(Minimum Information for Publication of Quantitative Real-Time PCR Experiments) 
guidelines (Bustin et al., 2009). An equal quantity (10–50 ng) of RNA was used in the 
TaqMan® assays. All single-tube TaqMan® assays were performed without a pre-
amplification except for the evaluation of miR-142-3p, miR-142-5p, and miR-146a, in 
which the pre-amplification step was performed as in the array assays. A total of 3-5 
biological replicates with 3 technical triplicates were performed for individual experiments.
Data analysis
Raw PCR Ct values were first determined using ViiA 7 RUO software (Life Technologies) 
with the same parameter settings across all samples (threshold set at 0.15 with automatic 
baseline). Data corresponding to failed QC as determined by ViiA 7 RUO software were 
excluded from the analysis. In addition, miRNAs with a PCR Ct value >35 were considered 
as undetectable. DataAssist® software (Life Technologies) was then used to analyze 
miRNA array data. Different array data from cytosol and mitochondria fractions were 
normalized separately. The Global Mean Normalization method (Mestdagh et al., 2009) was 
applied to normalize the pooled dataset of both Naïve and TBI. The Ct values presented in 
this report, including the Supplemental data, are normalized data. The miRNA expression 
levels between treatments (TBI vs Naïve) or mitochondria versus cytosol fractions from 
naïve rat brain samples were expressed as fold changes using the following equation: fold 
change=2^ −(CtTBI − CtNaive), or fold change=2^ −(CtMito − CtCyto), and were evaluated using 
an unpaired Student t-test. Benjamini-Hochberg or permutation tests were used to control 
False Discovery Rate (FDR), and all significant data points (p<0.05) had a FDR< 5%. The 
data from the TaqMan® single-tube miRNA RT-qPCR assays were compared using 
unpaired student t-tests with a p<0.05 considered as statistically significant.
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Results
Mitochondrial Purity
To examine the purity (and contamination) of our preparations, total mitochondria (MT) 
fractions were isolated from uninjured rat hippocampus and the proteins subjected to 
immunoblotting to test for the presence of cytosolic and nuclear protein components. As 
shown in Figure 1A, PDH, a mitochondrial matrix protein, was detected only in fractions 
containing mitochondria. Neither β-tubulin, a cytosolic protein marker, nor the nuclear 
protein marker, Histone H3, was detected in purified mitochondrial samples. The purity of 
the mitochondria preparation was further examined using RT-qPCR for the presence of 
cytosolic GAPDH mRNA (Figure 1B). Using this highly sensitive approach, GAPDH 
mRNA levels were found to be ~50-fold lower in the mitochondria preparation compared to 
the cytosolic fraction. Together, these experiments provide evidence that the mitochondria 
preparation used in our experiments was relatively free of cytoplasmic and nuclear 
contaminants.
Presence of AGO2-miRNA complexes in hippocampus mitochondria
The localization of AGO and Dicer in mitochondrial fractions of naïve rat brain was 
examined using immunoblotting with antibodies against AGO and Dicer. Western blot 
analysis demonstrated that both miRNA machinery proteins were enriched in mitochondrial 
matrix and outer membrane (Figure 2). The presence of miRNA machinery proteins in the 
mitochondrial fractions prompted us to examine whether these fractions also contain AGO-
associated miRNA complexes. The anti-AGO antibody 2A8 (Nelson et al., 2007) was used 
to co-immunoprecipitate (co-IP) AGO protein complexes (Wang et al., 2010) from isolated 
rat hippocampus mitochondrial (Mito-IP2A8) and cytosolic (Cyto-IP2A8) fractions. 
Western blot analysis of the IP products showed that the anti-AGO antibody 2A8 (IP2A8), 
but not normal mouse serum (IPNMS), effectively immunoprecipitated AGO2 from both the 
cytosolic and mitochondrial fractions (Figure 3 inset). Total RNA was extracted from the 
co-IP complexes and subjected to miRNA RT-qPCR TaqMan® assays for miR-124a and 
miR-107, two brain-enriched miRNAs (Wang et al., 2014), and miR-23a, which has been 
reported to be present in mitochondria (Das et al., 2012), as well as the small nuclear RNA 
U6. The RT-qPCR results demonstrated that these test miRNAs, but not U6, were co-
immunoprecipitated with and enriched in mitochondrial AGO complexes (Fig. 3). As 
expected, IP using normal mouse serum (IPNMS, data not shown) in the same preparation 
did not result in appreciable levels of these miRNAs.
Profiling of naïve hippocampal cytosolic and mitochondrial miRNAs
The TaqMan® RT-qPCR Array Rodent MicroRNA Card A (V2.0) (Life Technologies) was 
employed to analyze the global expression levels of miRNA associated with the 
mitochondria and, separately, the cytosolic fractions. A pre-amplification step using 
Megaplex™ PreAmp Primers was added to enhance the detection of low-expression 
miRNAs for both mitochondrial and cytosolic fractions. Quantitative PCR was performed 
using the ViiA™ 7 Real-Time PCR System (Life Technologies), and the data collected and 
processed using ViiA 7 RUO software (Life Technologies). Data that failed QC were 
excluded. In addition, individual miRNAs with a cycle threshold (Ct) value of 35 or higher 
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(Ct>35) were considered as undetectable and excluded from analysis. Using these criteria, 
285 out of 381 miRNAs in the Rodent Array Card A were detected in both cytosolic and 
mitochondrial fractions (Suppl. File 1). The overall miRNA expression levels in the cytosol 
were generally higher relative to mitochondria with an average Ct difference of 1.3, which is 
equivalent to a 2.5 fold higher level (Suppl. File 1). The largest differential expression was 
observed with rno-miR-333, where expression levels in cytosol were over 100-fold higher 
than that found in mitochondria.
Subset of miRNAs is enriched in naïve hippocampal mitochondria
Further analysis of the mitochondrial and cytosolic miRNA array data revealed contrasting 
miRNA expression pattern in samples from naïve rat hippocampi. While the levels of most 
miRNAs were found to be much higher in the cytosol, a subset of miRNAs including mmu-
miR-741, mmu-miR-142-5p, mmu-miR-302a, mmu-miR-142-3p, rno-miR-339-3p, mmu-
miR-10a, mmu-miR-146a, mmu-miR-202-3p, mmu-miR-150, mmu-miR-339-5p, and rno-
miR-344-5p were found to be at least 1.5 fold higher in mitochondria (Figure 4, Suppl. File 
2). Among these mitochondria-enriched miRNAs, miR-142-5p, miR-142-3p, and miR-146a 
were significantly higher (p<0.05, FDR < 5%) compared to levels in the cytosol. Although 
not statistically significant, miR-150 also displayed enrichment in mitochondria relative to 
the cytosol.
As a follow-up to the array data described above, TaqMan® single-tube RT-qPCR assays 
for miR-142-3p, miR-142-5p, miR-146a, miR-150 were carried out on RNA samples 
isolated from mitochondria and cytosol of naïve rat hippocampus (Figure 5A). We also 
examined the levels of miR-19b, a miRNA that did not display significantly different levels 
between cytosolic and mitochondria fractions, and U6, a small nuclear RNA that does not 
associate with mitochondria. The results of the single-tube TaqMan® assays confirmed that 
miR-142-3p, miR-142-5p, and miR-146a levels were significantly higher (p<0.05) in 
mitochondrial RNA samples relative to the cytosol. As observed in the array data, miR-150 
also showed higher trending levels in mitochondria relative to cytosol although not 
statistically significant (p=0.11). In comparison, miR-19b levels were not enriched in the 
mitochondria, and the small nuclear RNA U6 was approximately 13-fold less abundant in 
mitochondria relative to cytosol RNA. We also examined these same miRNAs in 
mitochondria and cytosolic fractions isolated from cultured primary rat brain astrocytes. The 
TaqMan® assays confirmed that miR-142-3p, miR-142-5p, and miR-146a levels were 2.30, 
2.42 and 2.26 fold higher, respectively, in astrocyte mitochondria than that found in cytosol 
(Figure 5B).
Altered expression of hippocampal mitochondria-associated miRNA following severe TBI
TBI resulted in altered expression levels of miRNA in both the hippocampal mitochondria 
and cytosol fractions at 12 hr following injury (Suppl. File 1). The TaqMan® RT-qPCR 
Array revealed that the differential overall expression levels of miRNAs in cytosol relative 
to mitochondria increased from 2.5 fold in naïve samples to 4.2 fold in injured hippocampus 
(Suppl. File 1). The levels of most mitochondria-associated miRNAs were decreased at this 
early time point following TBI (Table 1, Suppl. Files 1 and 2). In particular, mitochondria-
enriched miRNAs such as miR-142-3p, miR-142-5p, and miR-146a were decreased more 
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than two fold following TBI, while these miRNAs increased in cytosol. Follow-up single-
tube TaqMan® assays were used to confirm the initial array data (single-tube assays are 
presented in parentheses next to the array data in Table 1). The single-tube assays revealed 
that the mitochondria-enriched miRNAs, miR-142-3p and miR-142-5p were indeed 
significantly reduced in mitochondrial fractions while levels in cytosol were significantly 
increased (see Table 1 for p values). The levels of another mitochondria-enriched miRNA, 
miR-146a, were not significantly decreased in mitochondria (p=0.058), but were 
significantly higher (p=0.004) in cytosol.
The levels of several mitochondria-associated miRNAs were found to increase following 
TBI. Among them, miR-155 and miR-223 levels were significantly elevated to 7.3 and 4.63 
fold higher, respectively, in mitochondria fractions of injured relative to naïve (uninjured) 
rats (Table 1). To further validate these changes, single tube TaqMan® RT-qPCR was 
carried out for miR-155, miR-223, and a control miRNA, miR-19b, which did not change 
after injury. The levels of miR-155 and miR-223 were then normalized against the levels of 
miR-19b. RT-qPCR of hippocampal cytosolic and mitochondrial RNA preparations (n = 5 
animals in each group) showed that miR-155 and miR-223 were indeed significantly 
elevated following TBI (Figure 6), confirming the results of the array experiments. The fold 
changes observed in the single-tube RT-qPCR assays were much greater compared to the 
array data, which may be due to methodological differences, as well as differences in data 
normalization. Notably, in the single-tube RT-qPCR assay, the pre-amplification step was 
omitted, and the data normalized using miR-19b.
MiR-155 and miR-223 are recognized as two hematopoietic cell type specific miRNAs that 
are associated with hematopoiesis and leukocyte activation (Fazi et al., 2005; Landgraf et 
al., 2007; Rodriguez et al., 2007; Vigorito et al., 2007; Johnnidis et al., 2008). To examine 
the possibility that hematopoietic cell infiltration in injured rat hippocampus at 12 hr 
following TBI were what caused the miRNA expression we observed in our samples, we 
examined CD45 (pan leukocyte cell marker) expression in naïve and TBI hippocampal 
cytosolic protein preparations. CD45 levels did not increase in the samples at this early time 
point following TBI, indicating that the changes of miR-155 and miR-223 were not 
attributable to hematopoietic cell infiltration in response to injury (Suppl. Figure 1).
We further examined the expression of miRNAs in rat brain cell preparations that were 
enriched for particular cell types. TaqMan® miRNA RT-qPCR was used to detect miR-155, 
miR-223, miR-146a, miR-142-3p, miR-142-5p, miR-150, and miR-124a expression in 
enriched cortical neuron, astrocyte, and microglia cultures. The outcomes of this experiment 
demonstrated that miR-155, miR-223, miR-146a, miR-142-3p, miR-142-5p, and miR-150 
(data not shown) were detected in all three cell types but showed the highest expression in 
microglia and astrocytes (Fig 7), cell types that can mount immune responses. In contrast, 
levels of miR-124a were highest in the cortical neuronal cells as expected (Wang et al., 
2008b; Wang et al., 2014).
MiR-155 is known to participate in the regulation of inflammatory responses (Kurowska-
Stolarska et al., 2011; Moore et al., 2013), which also occur at early time points following 
TBI. Incubation of rat primary microglia and astrocyte cell cultures with lipopolysaccharide 
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(LPS) resulted in strong elevation of miR-155 levels in both cell types (p<0.001 for both 
microglia and astrocytes) (Fig 8). These experiments are consistent with prior findings that 
miR-155 is responsive to inflammatory mediators, such as LPS, in macrophages, monocytes, 
as well as microglia. Unlike miR-155, miR-223 was not elevated in either microglia and 
astrocyte cultures treated with LPS, suggesting that up-regulation of these two mRNAs in 
hippocampus following TBI may be driven by different signaling events.
Discussion
Mitochondria play a critical role in providing cellular energy and respond to a number of 
extracellular and intracellular environmental events. However, the signaling events that 
regulate miRNA function, especially their potential interactions with cellular organelles are 
largely unknown. Emerging research points to a possible interaction between miRNA and 
mitochondria (Maniataki and Mourelatos, 2005; Kren et al., 2009; Bian et al., 2010; 
Bandiera et al., 2011; Barrey et al., 2011; Huang et al., 2011; Das et al., 2012; Ernoult-
Lange et al., 2012; Latronico and Condorelli, 2012; Sripada et al., 2012), suggesting a 
potential novel pathway regulating miRNA function.
Prior studies have reported detection of miRNAs, ranging from 3 (Mercer et al., 2011) to 
428 (Sripada et al., 2012), within or associated with mitochondria from various tissues and 
cell types (Lung et al., 2006; Kren et al., 2009; Bian et al., 2010; Bandiera et al., 2011; 
Barrey et al., 2011; Huang et al., 2011; Mercer et al., 2011; Das et al., 2012; Sripada et al., 
2012). In the present study, the miRNA TaqMan® qPCR array detected 285 miRNAs in 
highly purified naïve hippocampal mitochondria preparations. In addition, although the 
average expression level of most of these miRNAs was 2.5-fold lower than the same 
miRNA in the cytosol, several miRNAs were preferentially enriched in the mitochondria 
preparations. Among them, mitochondria-enriched miR-142-3p, miR-142-5p, miR-146a, 
and miR-150 were further validated using RT-qPCR conducted on mitochondrial RNA 
isolated from cultured primary rat astrocytes. Previous studies have shown that miR-146a is 
enriched in mitochondria from human 143B cells (Mercer et al., 2011) as well as mouse 
liver (Bian et al., 2010). Interestingly, all of these mitochondria-associated miRNAs are 
known to be involved in immune function and inflammatory responses (Landgraf et al., 
2007; Xiao et al., 2007; Sonkoly et al., 2008; Sun et al., 2010; Vasilatou et al., 2010). Taken 
together, these studies suggest the possible existence of a regulatory process by which 
certain miRNA or miRNA families are partitioned to mitochondria based on common 
functional domains.
The 12hr post-injury time point we examined corresponds to a dynamic period when 
mitochondrial dysfunction, oxidative damage, and cell death are ongoing in the 
hippocampus (Baldwin et al., 1997; Lifshitz et al., 2003; Ansari et al., 2008; Davis et al., 
2008; Gilmer et al., 2009). Therefore, it is of interest that mitochondria-associated miRNAs 
in the hippocampus displayed significant changes at 12 hr following TBI. Importantly, 
mitochondria-enriched miRNAs, such as miR-142-3p, miR-142-5p, and miR-146a were all 
decreased at this early time point, while levels of the same miRNA increased in the cytosol. 
Any mechanistic explanation for this shift in expression levels at this early time point is 
unclear. The ficoll isolation procedure we used captures only intact mitochondria that are at 
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different stages of compromised function. Therefore, we believe that the mitochondria to 
cytosol shift reflects a true mechanistic event in response to TBI-related cellular stressors. It 
is interesting to note that mitochondria in the hippocampus respond to TBI differently than 
cortical mitochondria, especially at early time points (Lifshitz et al., 2003; Lifshitz et al., 
2004). In particular, cortical mitochondria are structurally and functionally more 
compromised compared to mitochondria from the hippocampus, which is consistent with 
differences in cell death responses between these two brain regions (Dietrich et al., 1994; 
Hicks et al., 1996; Lifshitz et al., 2003; Lifshitz et al., 2004). It is possible that the structural 
and functional changes that occur in the mitochondria are responsible for the observed shift 
in miRNA expression patterns. If this indeed is occurring, it will be important to determine 
the functional consequences as well as the cell type(s) impacted by this shift in miRNA 
expression patterns. This differential temporal and regional response to TBI also guided our 
decision to examine changes in mitochondria associated miRNA from the hippocampal 
formation at 12 hr following injury. Our observations suggest that mitochondria-associated 
miRNAs in the hippocampus are highly sensitive to cellular changes and respond to cellular 
stressors by translocating from the mitochondrial to the cytosolic compartment. 
Alternatively, these specific miRNAs may be up-regulated in the cytosol after TBI 
independent of what is occurring in the mitochondrial compartment. Regardless, the 
observation that levels of mitochondria-enriched miRNA decreased after TBI suggests a 
potential mechanism by which miRNA function may be regulated in cells under conditions 
of duress.
The levels of miR-155 and miR-223, both of which play a role in several biological/
pathological processes including immunity, cancer, and inflammatory responses (Sonkoly et 
al., 2008; Quinn and O’Neill, 2011; Higgs and Slack, 2013; Vigorito et al., 2013; Seddiki et 
al., 2014; Taibi et al., 2014), were significantly elevated in both the mitochondria as well as 
cytosolic fractions. MiR-223 levels have previously been shown to be elevated in rat total 
hippocampal tissue, or cerebral cortex homogenates at different times following TBI (Lei et 
al., 2009; Redell et al., 2009). Interestingly, miR-155 levels were found to increase in 
mitochondria isolated from mouse liver after streptozotocin treatment, which is known to 
produce Type 1 diabetes in animal model and impair mitochondria function (Bian et al., 
2010). We further tested the potential signaling pathways that trigger elevated miR-155 and 
miR-223 by treating primary astrocyte and microglia cells with LPS, which activates the 
Toll-like receptor signaling pathway leading to an inflammatory response (Hoshino et al., 
1999). The results of this experiment demonstrated that miR-155, but not miR-223, was 
significantly up-regulated in both astrocyte and microglia following LPS treatment. One 
explanation for this differential effect of LPS is that the up-regulation of miR-155 and 
miR-223 in the hippocampus following TBI may be driven by different injury-related 
signaling events.
Recent studies have reported changes in several miRNAs in the hippocampus following TBI 
(Lei et al., 2009; Redell et al., 2009; Redell et al., 2010; Truettner et al., 2011; Hu et al., 
2012; Truettner et al., 2013; Liu et al., 2014; Sabirzhanov et al., 2014; Sun et al., 2014). The 
results of our experiments revealed an increase in miR-223 in both mitochondria and 
cytosol, which is consistent with the results of previous studies using the same injury model 
and whole tissue homogenates (Lei et al., 2009; Redell et al., 2009) However, we did not 
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detect significant changes in levels of several other miRNAs, (such as miR-107 and miR-21) 
that have been reported to respond to TBI. It is difficult to compare the results of the present 
study examining changes in mitochondrial versus cytoplasmic miRNA levels with existing 
studies that examined miRNA changes in whole tissue homogenates. In addition, we chose 
the 12hr post-injury recovery period as it captures an early time point when there is a 
maximal loss of bioenergetics and structural integrity in hippocampal mitochondria 
following the injury (Lifshitz et al., 2003; Singh et al., 2006; Gilmer et al., 2009). Finally, 
differences in the injury model and the miRNA assay systems used may contribute to some 
of the variations in the results observed across studies. Therefore, it will be important to 
examine changes in mitochondrial and cytosolic miRNA expression patterns at other time 
points using the same injury model and miRNA detection system.
TBI induces secondary signaling events that are biochemically relevant to functional 
recovery (McIntosh et al., 1998; Rosenfeld et al., 2012). Overall, the results of our study 
suggest that mitochondria-associated miRNAs actively participate in the response to TBI. 
However, the events contributing to mitochondria and miRNA interactions, and the 
mechanism(s) affecting altered mitochondria-associated miRNA levels following TBI are 
still largely unknown. A previous study has demonstrated a dynamic interaction between 
mitochondria and miRNA associated processing bodies (P-bodies) (Huang et al., 2011). 
Interestingly, this same study reported that treatment of mitochondria with an uncoupling 
agent resulted in delocalization of AGO from P-bodies, which led to a significant decrease 
in miRNA mediated RNAi efficiency. Although additional studies are required to reveal the 
crosstalk and trafficking of miRNAs between mitochondria, cytosol, and other cellular 
organelles/compartments, this study raises the possibility that mitochondria play a role in 
regulating miRNA function. Future studies exploring this dynamic interaction, and its 
implication in various pathophysiological processes may lead to a better understanding of 
secondary damage following TBI.
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Highlights
MiRNA machinery proteins Argonaute and Dicer are present in hippocampal 
mitochondria
Several miRNAs are enriched in hippocampal mitochondria under normal conditions
Numerous mitochondria-associated miRNAs are significantly altered following TBI
MiRNAs enriched in mitochondria decreased and cytosolic levels increased after 
TBI
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Figure 1. Purity of isolated mitochondria
Western blot analysis and RT-qPCR were used to examine the purity of isolated 
mitochondria. The results suggested that the mitochondria preparations were relatively free 
from cytosolic or nuclear contaminations. A. Rat hippocampal cytosolic, mitochondrial, and 
nuclear proteins were subjected to Western blot analysis using β-tubulin (cytosol marker), 
PDH (mitochondria marker), and Histone H3 (nuclear marker) antibodies. 1: Total brain 
homogenate; 2: Total hippocampal homogenate; 3: Cytosolic fraction; 4: Nuclear fraction; 5 
and 7: Blank; 6: Mitochondrial fraction with 2X ficoll gradient; 8: Mitochondrial fraction 
with 1X Ficoll gradient. B. TaqMan® RT-qPCR for GAPDH in cytosol and mitochondria 
preparations. Cyto: cytosol; Mito: mitochondria.
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Figure 2. MiRNA machinery proteins Dicer and AGO2 were present in rat brain mitochondria
Isolated mitochondria and mitochondrial subfractions were analyzed for Dicer and AGO2 
using Western blotting. Antibodies against marker proteins for the mitochondria 
subfractions included VDAC (outer membrane), CoxIV (inner membrane), and PDH 
(matrix). Brain Homog.: total brain homogenate; Total MT: total mitochondria lysate; MS: 
mitochondrial supernatant containing broken outer membrane and inter-membrane space 
compartments; OM: outer membrane; IMS: inter-membrane space; MP: mitoplast; IM: inner 
membrane; MTX: mitochondria matrix.
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Figure 3. Enrichment of mitochondrial miRNA in AGO complexes
Co-immunoprecipitation (co-IP) with anti-AGO 2A8 antibody was performed using isolated 
total mitochondrial lysate. Corresponding cytosols were also subjected to co-IP. The co-IP 
RNAs were extracted and analyzed using RT-qPCR TaqMan® assays for miR-23a, 
miR-107, and miR-124a, and a control small nuclear RNA U6. MiRNAs were specifically 
enriched in anti-AGO 2A8 antibody co-immunoprecipitates (IP2A8), while co-IP using 
normal mouse serum (IPNMS, data not shown) did not result in any specific signal. As 
expected, U6, which does not associate with AGO complexes was not detected in co-IP 
RNA samples. Inset: Western blot analysis of the IP products using anti-AGO 2A8 antibody 
(IP2A8) or normal mouse serum (IPNMS). TL: total lysate.
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Figure 4. Differential miRNA enrichment in cytosol and mitochondria
Volcano plot of RT-qPCR array data displayed differential miRNA enrichment in cytosol 
and mitochondria. Each data point was plotted as the level of fold change 
(Log2(Fold Change—Mito vs Cyto)) on the X-axis and corresponding statistical level of 
significance (−log10(p value)) on the y-axis. Fold change=2^ −(CtMito − CtCyto). Mitochondria-
enriched miRNAs with a more than 2 fold change were colored in red; likewise, cytosol-
enriched miRNAs that having a change more than 2 fold were colored in green. Data points 
above the red-dashed-line are statistically significant (p < 0.05). The numeric data set of this 
plot is provided in Suppl. File 2.
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Figure 5. Subset of miRNAs was enriched in mitochondria
Single-tube TaqMan® assays further validated that a subset of miRNAs was enriched in 
mitochondria. TaqMan® assays for the indicated miRNAs and U6 were performed using rat 
hippocampal mitochondrial (Mito) and cytosolic (Cyto) preparations (A), or rat cortical 
astrocyte mitochondrial and cytosolic preparations (B). The results demonstrated that 
miR-142-3p, miR-142-5p, and miR-146a are enriched in mitochondrial fractions, which is 
consistent with the array findings.
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Figure 6. MiR-155 and miR-223 were highly elevated following TBI
Single-tube TaqMan® assays for miR-155 and miR-223 using mitochondrial (Mito) and 
cytosolic (Cyto) preparations from TBI and naïve rat hippocampi demonstrated a strong 
induction of these two miRNAs following TBI in both mitochondrial and cytosolic fractions. 
Fold change was calculated relative to the levels observed in naïve samples.
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Figure 7. MiR-155, miR-223, miR-146a, miR-142-3p, miR-142-5p, and miR-150 are detected in 
rat brain cells
TaqMan® assays for miR-155, miR-223, miR-146a, miR-142-3p, miR-142-5p, and 
miR-150 (not shown) were performed using total RNAs isolated from untreated primary 
cortical neuron, astrocyte, and microglia enriched cultures. These miRNAs were readily 
detected in all three primary cell types with high expression levels in the astrocyte and 
microglial cells. As a control, a neuronal enriched miRNA, miR-124a, was tested in parallel. 
Expression levels of miRNAs are presented as fold change relative to levels in primary 
cortical neurons. The one exception is miR-124a, the levels of which are expressed relative 
to levels in primary astrocytes. Average Ct values of neuronal RNA samples were 28.2, 
26.6, 28.0, 23.9, 28.9, 23.1, and 19.1 for miR-155, miR-223, miR-150, miR-146a, 
miR-142-3p, miR-142-5p, and miR-124a, respectively.
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Figure 8. MiR-155 responds to LPS treatments in rat astrocyte and microglia
TaqMan® assays for miR-155 (A) and miR-223 (B). There was a significant elevation of 
miR-155, but not miR-223, in response to LPS treatment in both astrocyte and microglia cell 
cultures; These results suggest that the up-regulation of miR-155 and miR-223 in 
hippocampus following TBI may be driven by different signaling pathways. C. Western blot 
analysis showed that iNOS was induced in response to LPS treatment in primary microglial 
cell cultures. Fold change was calculated relative to the levels detected in untreated control 
cells.
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Table 1
Changes in mitochondria-associated and cytosolic miRNAs at 12 hr following TBI
List of miRNAs with significant changes based on the RT-qPCR array analysis. Data and p values presented 
in parentheses were follow-up studies using single-tube TaqMan assay analysis. Red and green colors 
designate miRNA that significantly increased or decreased, respectively, in each fraction. Fold difference of 
each miRNA was calculated following the formula: Fold Change=2^ −(CtTBI − CtNaive). Permutation test was 
used to control False Discovery Rate (FDR). All significant data point (p<0.05) has a FDR< 5%.
Mitochondria Cytosol
miRNA Fold Change (TBI vs Naïve) P Value Fold Change (TBI vs Naïve) P Value
mmu-miR-155 7.30 0.023 5.2 0.05
mmu-miR-223 4.63 0.021 14.9 3.2E-06
mmu-miR-15a 0.66 0.043 1.06 0.885
rno-miR-421 0.65 0.048 1.13 0.705
mmu-miR-532-3p 0.56 0.014 1.05 0.881
rno-miR-532-5p 0.56 0.019 1.11 0.646
mmu-miR-344 0.54 0.045 0.97 0.885
mmu-miR-187 0.52 0.0008 0.76 0.140
mmu-miR-434-5p 0.52 0.038 0.90 0.727
mmu-miR-142-5p 0.28 (0.5) 0.031 (0.004) 2.02 (1.95) 0.168 (0.022)
mmu-miR-1 0.23 0.017 0.63 0.458
mmu-miR-10a 0.17 0.033 1.39 0.767
mmu-miR-743a 0.06 0.009 2.30 0.552
mmu-miR-142-3p 0.47 (0.49) 0.176 (0.0004) 2.15 (1.73) 0.112 (0.008)
mmu-miR-292-3p 5.18 0.140 8.61 0.074
rno-miR-224 1.87 0.571 5.11 0.058
mmu-miR-224 1.67 0.621 3.77 0.015
mmu-miR-200c 0.82 0.694 1.67 0.068
mmu-miR-682 2.33 0.245 1.55 0.024
mmu-miR-146a 0.44 (0.61) 0.134 (0.058) 1.47 (1.40) 0.251 (0.004)
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